Nov 17, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Interpreting Haemonetics ( HAE ) International Revenue Trends
Review Haemonetics' (HAE) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Nov 14, 2025 • Zacks Commentary
BULLISH
Here's Why Haemonetics ( HAE ) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Nov 13, 2025 • Benzinga
BULLISH
UPDATE Headwall Appoints Tim Spang as Chief Executive Officer
Bolton, Massachusetts, Nov. 13, 2025 ( GLOBE NEWSWIRE ) -- The Board of Directors of Headwall Group ( "Headwall" ) , a leader in advanced hyperspectral imaging technology and a portfolio company of private equity firm Arsenal Capital Partners, today announced that it has appointed Tim Spang as ...
Nov 13, 2025 • Benzinga
BULLISH
Headwall Appoints Tim Spang as Chief Executive Officer
Bolton, Massachusetts, Nov. 13, 2025 ( GLOBE NEWSWIRE ) -- The Board of Directors of Headwall Group ( "Headwall" ) , a leader in advanced hyperspectral imaging technology and a portfolio company of private equity firm Arsenal Capital Partners, today announced that it has appointed Tim Spang as ...
Nov 13, 2025 • Zacks Commentary
BULLISH
Why Haemonetics ( HAE ) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Nov 11, 2025 • Zacks Commentary
BULLISH
Haemonetics ( HAE ) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.